BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 17936004)

  • 1. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
    Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
    Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical pathological study on nodal micrometastases of non-small-cell lung cancer].
    Wang YX; Chu XY; Sun YE; Wang ZB; Li XH; Zhang GK
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(2):114-7. PubMed ID: 17418040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
    Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
    Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.
    Sato F; Shimada Y; Li Z; Watanabe G; Maeda M; Imamura M
    Br J Surg; 2001 Mar; 88(3):426-32. PubMed ID: 11260111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of occult tumor cells in resected lymph nodes of patients with stage I carcinoma and its clinico-pathological significance].
    Chen Z; Lu X; Huang R
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):69-71. PubMed ID: 10743062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis.
    Qiu Y; Yang H; Chen H; Ge L; Xu X; Xiong X; He J
    Jpn J Clin Oncol; 2010 Feb; 40(2):146-52. PubMed ID: 19897851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modality of failure following resection of stage I and stage II non-small cell lung cancer.
    Ramacciato G; Paolini A; Volpino P; Aurello P; Balesh AM; D'Andrea N; Del Grande E; Passaro U; Tosato F; Fegiz G
    Int Surg; 1995; 80(2):156-61. PubMed ID: 8530234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
    Doddoli C; Aragon A; Barlesi F; Chetaille B; Robitail S; Giudicelli R; Fuentes P; Thomas P
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):680-5. PubMed ID: 15784374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry-detected microscopic tumor spread affects outcome in en-bloc resection for T3-chest wall lung cancer.
    Mineo TC; Ambrogi V; Pompeo E; Baldi A
    Eur J Cardiothorac Surg; 2007 Jun; 31(6):1120-4. PubMed ID: 17400469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.